AU1123501A - Methylation of unstable sequences - Google Patents

Methylation of unstable sequences

Info

Publication number
AU1123501A
AU1123501A AU11235/01A AU1123501A AU1123501A AU 1123501 A AU1123501 A AU 1123501A AU 11235/01 A AU11235/01 A AU 11235/01A AU 1123501 A AU1123501 A AU 1123501A AU 1123501 A AU1123501 A AU 1123501A
Authority
AU
Australia
Prior art keywords
methylation
unstable sequences
unstable
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11235/01A
Inventor
Christopher Edmund Pearson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hospital for Sick Children HSC
Original Assignee
Hospital for Sick Children HSC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hospital for Sick Children HSC filed Critical Hospital for Sick Children HSC
Publication of AU1123501A publication Critical patent/AU1123501A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
AU11235/01A 1999-10-29 2000-10-30 Methylation of unstable sequences Abandoned AU1123501A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16215299P 1999-10-29 1999-10-29
US60162152 1999-10-29
PCT/CA2000/001286 WO2001032857A1 (en) 1999-10-29 2000-10-30 Methylation of unstable sequences

Publications (1)

Publication Number Publication Date
AU1123501A true AU1123501A (en) 2001-05-14

Family

ID=22584381

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11235/01A Abandoned AU1123501A (en) 1999-10-29 2000-10-30 Methylation of unstable sequences

Country Status (3)

Country Link
AU (1) AU1123501A (en)
CA (1) CA2389334A1 (en)
WO (1) WO2001032857A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2291367A1 (en) * 1999-12-06 2001-06-06 Isabelle Henry Genetic constructions having a reduced or an increased number of epigenetic control regions and methods of use thereof
US11680273B2 (en) 2011-09-23 2023-06-20 Loma Linda University Treatment of autoimmune diseases
US10813987B2 (en) 2011-09-23 2020-10-27 Loma Linda University Method for inducing a tolerogenic immune response

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748119A (en) * 1983-09-19 1988-05-31 Alexander Rich Process for altering and regulating gene expression
US5534428A (en) * 1994-09-06 1996-07-09 Life Technologies, Inc. Cloned Ssti/SacI restriction-modification system
WO1997011972A1 (en) * 1995-09-28 1997-04-03 The Trustees Of Columbia University In The City Of New York Chimeric dna-binding/dna methyltransferase nucleic acid and polypeptide and uses thereof

Also Published As

Publication number Publication date
CA2389334A1 (en) 2001-05-10
WO2001032857A1 (en) 2001-05-10

Similar Documents

Publication Publication Date Title
AU3867400A (en) Methods of using bioelastomers
AU2754700A (en) Busy-wait-free synchronization
AU2718301A (en) Synchronization of nodes
AU4141300A (en) Expandable connector
AU5743200A (en) Protection of communications
AU2557500A (en) Methods of making compounds
AU6111000A (en) Inhibitors of viral helcase
AU1488501A (en) Methods of inhibiting metastasis
AU4439700A (en) Insulator
AU6359400A (en) Production of aliphatic fluorocarbons
AU7319800A (en) 4-oxybenzopyran derivative
AU6564600A (en) Copolymers of acryloyloxyalkylamino compounds
AUPQ262599A0 (en) Gene expression
AU7453900A (en) 4-oxybenzopyran derivative
AU6690300A (en) Copolymers of acryloylaminoalkyl compounds
AU5698400A (en) Sulphamate compounds
AU4369000A (en) Inhibition of complement action
AU1082701A (en) Short segments of dap-kinase
AU1812801A (en) Short shared nucleotide sequences
AU5433699A (en) Spacing of tiles
AU7606100A (en) Gene expression profiles
EP1144631A3 (en) Insulin-synthesis genes
AU1123501A (en) Methylation of unstable sequences
PL352409A1 (en) Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane
AU7461900A (en) Nucleotide sequences

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase